Cite
APA Citation
Ranganathan, U., Merrill, J., Crow, M., Delev, N., Banerjee, S., Grasela, D., Harrison, M., Shen, Y., Culotta, E., Greenberg, S., & Shah, V. (n.d.). pO.6.132 A phase 2b study of afimetoran (BMS-986256) in patients with active systemic lupus erythematosus (SLE): optimization of a lupus clinical trial design. Lupus science & medicine, 9, A100–A101. http://access.bl.uk/ark:/81055/vdc_100167558961.0x00000b